五例儿童呼吸系统疾病病例的临床药学服务评价: 一项综合性研究

doi:10.5246/jcps.2025.07.051

中国药学(英文版) ›› 2025, Vol. 34 ›› Issue (7): 682-690.DOI: 10.5246/jcps.2025.07.051

五例儿童呼吸系统疾病病例的临床药学服务评价: 一项综合性研究

韩思怡, 卫雅楠, 史乃月, 王宇航, 来琳琳^*()

沈阳药科大学生命科学与生物制药学院, 辽宁沈阳 110016

收稿日期:2025-02-18 修回日期:2025-03-24 接受日期:2025-04-11 出版日期:2025-07-31 发布日期:2025-07-31
通讯作者: 来琳琳

Clinical pharmacy services evaluation across five pediatric respiratory disease cases: A comprehensive study

Siyi Han, Yanan Wei, Naiyue Shi, Yuhang Wang, Linlin Lai^*()

School of Life Sciences and Biopharmaceuticals, Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China

Received:2025-02-18 Revised:2025-03-24 Accepted:2025-04-11 Online:2025-07-31 Published:2025-07-31
Contact: Linlin Lai
Supported by:
National Natural Science Foundation of China (Grant No. 21302131).

摘要/Abstract

摘要：

本文探讨临床药师对儿童呼吸系统疾病患者实现合理化用药的途径。从病历中提取患者的病原学检查、症状学信息以及用药信息, 结合丁香园、用药助手软件(手机版)、MCDEX软件(移动版)等相关软件, 维普、知网等数据库相关文献对患者的用药方案进行合理性分析, 结合患者年龄特点、用药方案和疾病特点分析该患者药学服务的重点内容和注意事项。针对患者年龄特点、用药方案和疾病特点提供个体化药学服务和用药教育。结果发现, 药师通过参与个体化用药工作, 提供针对每位患者的个体化用药服务, 可以更好地确保患者用药的安全有效。

关键词: 儿童, 呼吸系统, 用药服务, 临床药师

Abstract:

The aim of this study is to investigate how clinical pharmacists can optimize drug use for pediatric patients with respiratory diseases. We extracted etiological, symptomatic, and medication-related information from patient medical records. The rationality of each patient’s medication regimen was evaluated using relevant tools, including DXY, Medication Assistant Software (mobile version), MCDEX Software (mobile version), and literature from databases such as VIP and CNKI. By considering the patients’ age, prescribed medication regimens, and disease characteristics, we identified key aspects and precautions for pharmaceutical care. Pharmacists provided tailored pharmaceutical care and medication education based on each patient’s specific age, treatment plan, and illness profile. Through active involvement in personalized medication management, pharmacists can offer individualized drug services, enhancing both the safety and effectiveness of treatments for pediatric patients.

Key words: Children, Respiratory system, Medication services, Clinical pharmacist

Supporting:

韩思怡, 卫雅楠, 史乃月, 王宇航, 来琳琳. 五例儿童呼吸系统疾病病例的临床药学服务评价: 一项综合性研究[J]. 中国药学(英文版), 2025, 34(7): 682-690.

Siyi Han, Yanan Wei, Naiyue Shi, Yuhang Wang, Linlin Lai. Clinical pharmacy services evaluation across five pediatric respiratory disease cases: A comprehensive study[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(7): 682-690.

图/表 1

参考文献 20

[1]	Han, Y.X.; Huang, Y.Y.; Zhao, R.L. Analysis of 1188 drug consultation records in children. Chin. J. Clin. Pharm. 2020, 29, 136–139.
[2]	Sharland, M.; Gandra, S.; Huttner, B.; Moja, L.; Pulcini, C.; Zeng, M.; Mendelson, M.; Cappello, B.; Cooke, G.; Magrini, N.; EML Expert Committee and Antibiotic Working Group. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool. Lancet Infect. Dis. 2019, 19, 1278–1280.
[3]	Ni, X. Community-acquired pneumonia diagnosis and treatment norms for children (2019 edition). Clin. Educ. Gen. Pract. 2019, 17, 771–777.
[4]	Kimberlin, D.W.; Brady, M.T.; Jackson, M.A.; Long, S. Red book: 2015 report of the committee on infectious diseases. 30th ed. EIk Grove Village: American Academy of Pediatrics. 2015, 883, 889.
[5]	Young, T.E. Neofax 2011, 24th ed. New York: Thomson Reuters. 2011, 16–17.
[6]	Zhao, S.Y.; Chen, Z.M.; Liu, H.M.; Zhao, D.Y.; Hong, J.G.; Lu, Q. Highlights of the National Health Commission’s Guidelines for the Diagnosis and Treatment of Mycoplasma pneumoniae in Children (2023 Edition). J. Clin. Paediatr. 2023, 41, 224–228.
[7]	Tang, J.Y.; Wang, Q.; Wu, S.J.; Xu, H.F.; Zhang, S.H. Zhang, G. Efficacy and safety of different-course intravenous azithromycin treatments for mycoplasmal pneumonia in children: a Meta-analysis. China Pharmacist. 2020, 23, 97–100.
[8]	Stokholm, J.; Chawes, B.L.; Vissing, N.H.; Bjarnadóttir, E.; Pedersen, T.M.; Vinding, R.K.; Schoos, A.M M.; Wolsk, H.M.; Thorsteinsdóttir, S.; Hallas, H.W.; Arianto, L.; Schjørring, S.; Krogfelt, K.A.; Fischer, T.K.; Pipper, C.B.; Bønnelykke, K.; Bisgaard, H. Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years: a randomised, double-blind, placebo-controlled trial. Lancet Respir. Med. 2016, 4, 19–26.
[9]	Li, W.J.; Lu, M.Q.; Xu, A.L.; Xi, X.Y. Comparison and thinking of drug dosage forms for children of different ages at home and abroad. Chin. Hosp. Pharm. J. 2019, 39, 2236–2239.
[10]	Wei, K.X.; Luo, J. Research progress on medication education of inhaled preparation. Guangxi Med. J. 2022, 44, 1661–1663, 1689.
[11]	Giraud, V.; Allaert, F.A.; Roche, N. Inhaler technique and asthma: Feasability and acceptability of training by pharmacists. Respir. Med. 2011, 105, 1815–1822.
[12]	Xue, J.Y.; Zhang, X.Y.; Cheng, J. Application effect of psychological nursing in emergency pediatric intravenous infusion nursing. Clin. Res. Pra. 2022, 7, 160–162.
[13]	Qiu, K.F.; He, Z.C.; Chen, Z.P.; Zhu. J.H.; Zheng, Z.H.; Wu, J.Y. Interpretation of the group standard "Code for evidence-based evaluation of over-the-counter medication". Phram. Today. 2021, 31, 811–814.
[14]	Zha, L.; Wang, C.J.; Ji, J.J. Investigation on the off-label drug use in pediatric outpatients based on evidence-based pharmacy. Pract. Pharm. Clin. Remed. 2019, 22, 1091–1095.
[15]	Ramirez, J.; Guarner, F.; Bustos Fernandez, L.; Maruy, A.; Sdepanian, V.L.; Cohen, H. Antibiotics as major disruptors of gut microbiota. Front. Cell. Infect. Microbiol. 2020, 10, 572912.
[16]	Zheng, Y.J.; Wu, Q.B.; Fang, F.; Chen, J.; Shang, Y.X.; Fu, Z.; Zhang, L.; Lu, M.; Cao, L.; Cui. H.; Peng, S.; Qu, S.Q.; Yang, Y.H.; Shen, K.L. Expert consensus on the diagnosis, treatment and prevention of antibiotic-associated diarrhea in children. Chin. J. Appl. Clin. Pediatr. 2021, 36, 424–430.
[17]	Fan, Z.; He, J.F.; Huang, J.; Chen, B.B. Correlation of vitamin D levels with recurrent respiratory infections and immune function in children. Chin. J. Matern. Child Health Care. 2023, 38, 1033–1036.
[18]	Kong, X.Y.; Chen, Q.; Wu, X.; Bian, H.M.; Li, Y. The research progress of interaction between Chinese and western medicine combination. J. Nanjing Univ. Tradit. Chin. Med. 2018, 34, 5–11.
[19]	Hu, L.; Ma, Z, Y.; Lv, Y. Correlation between antibiotic use and parental anxiety and depression in children with respiratory diseases. Chin. J. Lab. Diagn. 2022, 26, 983–987.
[20]	Yu, S.; Li, Y.; Zhong, Z. Investigation on knowledge, attitude and practice about antibiotic among 1445 children’s parents. Matern. Child Health Care China. 2022, 37, 3980–3983.

五例儿童呼吸系统疾病病例的临床药学服务评价: 一项综合性研究

Clinical pharmacy services evaluation across five pediatric respiratory disease cases: A comprehensive study

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 1

参考文献 20

相关文章 11

编辑推荐

Metrics

本文评价

[1]	李惟妙, 陈敬, 史录文. 中国《鼓励研发申报儿童药品清单》的政策实施效果[J]. 中国药学(英文版), 2025, 34(3): 260-268.
[2]	涂颖秋, 赖敏芳, 钟楠, 曹洪晓, 黄正刚. 13岁以下儿童使用泊沙康唑口服混悬液的真实世界安全性研究[J]. 中国药学(英文版), 2024, 33(4): 352-357.
[3]	钱利荣, 高丽娜. 口服与静脉大环内酯类抗菌药在治疗肺炎支原体引发的儿科肺炎中的疗效比较[J]. 中国药学(英文版), 2024, 33(12): 1146-1152.
[4]	袁叶, 杨珍珍, 于博, 杨秀岭. 1例合并附壁血栓的缺血性心肌病心衰患者的用药分析及药学服务[J]. 中国药学(英文版), 2024, 33(1): 63-68.
[5]	袁叶, 于博, 杨珍珍, 董维冲, 杨秀岭. 达格列净在血容量不足患者中的药学监护及文献分析[J]. 中国药学(英文版), 2022, 31(9): 718-722.
[6]	严荧燕, 毛佩芝, 陈漪, 沈珑慧. 儿童医院门急诊布洛芬和对乙酰氨基酚交替使用分析[J]. 中国药学(英文版), 2022, 31(5): 369-373.
[7]	武海艳, 张翔, 丁珊珊, 张国华, 唐琳琳, 唐琳. 儿童难治性支原体肺炎的抗支原体药物治疗进展[J]. 中国药学(英文版), 2022, 31(5): 334-342.
[8]	邵淑容, 郭卫. 静脉注射人免疫球蛋白临床应用的不良反应之三年回顾性研究[J]. 中国药学(英文版), 2019, 28(1): 56-61.
[9]	朱愿超, 胡永芳, 杨莉萍, 胡欣. 临床药师干预对甲状腺手术围术期预防应用抗菌药物的影响[J]. 中国药学(英文版), 2015, 24(9): 617-624.
[10]	张金莲, 周佳, 陈霁晖, 陈婷, 刘艳, 田怀平, 张健. 临床药师对婴幼儿万古霉素血药浓度监测情况分析[J]. 中国药学(英文版), 2015, 24(4): 263-266.
[11]	包宁疆, 邵宏^*, 聂小燕, 吴永佩, 颜青, 李喜西, 杨巍, 王宁, 郑凯, 魏艳红, 史录文. 我国临床药师培训试点情况调查与分析[J]. , 2011, 20(4): 410-414.